2024-2025 COVID Vaccine: CDC 2nd Dose Recommendation
- Atlanta — The Centers for Disease Control and Prevention (CDC) is now recommending a second dose of the 2024-2025 COVID-19 vaccine for individuals aged 65 and older, as...
- The updated guidelines also provide flexibility for immunocompromised individuals to receive additional doses, determined in consultation with their healthcare provider. This approach,known as shared clinical decision-making,aims to optimize...
- The CDCS recommendation underscores the heightened risk of severe COVID-19 outcomes in older adults and immunocompromised individuals.
The CDC now recommends a second dose of the 2024-2025 COVID-19 vaccine for those 65+,and individuals with moderate or severe immunocompromise—safeguarding against severe outcomes. This critical update, endorsed by CDC Director Mandy Cohen, advises a second shot six months after the first. The guidelines also offer flexibility for immunocompromised individuals too get additional doses, decided in consultation with their healthcare providers.The approach emphasizes shared clinical decision-making,aiming to optimize protection. The recommendations underscore the importance of the primary_keyword in vulnerable populations with the secondary_keyword playing a crucial role in protection. News Directory 3 brings you the latest on this evolving story. Discover what’s next concerning vaccination updates.
CDC Recommends second COVID-19 Vaccine Dose for High-Risk Groups
Atlanta — The Centers for Disease Control and Prevention (CDC) is now recommending a second dose of the 2024-2025 COVID-19 vaccine for individuals aged 65 and older, as well as those who are moderately or severely immunocompromised. CDC Director Mandy Cohen endorsed the Advisory Committee on Immunization Practices’ (ACIP) advice, advising that the second shot be administered six months following the initial dose.
The updated guidelines also provide flexibility for immunocompromised individuals to receive additional doses, determined in consultation with their healthcare provider. This approach,known as shared clinical decision-making,aims to optimize protection for those most vulnerable.
The CDCS recommendation underscores the heightened risk of severe COVID-19 outcomes in older adults and immunocompromised individuals. It also considers available data on vaccine effectiveness and the ongoing circulation of the virus. The agency aims to clarify dosage guidelines for healthcare providers and improve vaccination rates among the immunocompromised.
According to the CDC, current data reinforces the importance of vaccination in safeguarding those at greatest risk from COVID-19. The updated 2024-2025 COVID-19 vaccines can restore and boost protection against prevalent virus variants. Vaccination also reduces the likelihood of developing Long COVID.
the CDC and ACIP will continue to monitor vaccine safety and effectiveness. The agency urges everyone to stay up to date with COVID-19 vaccines, particularly those 65 and older and individuals with weakened immune systems.
“This vote allows people to make the best decisions possible to keep themselves and their loved ones safe from COVID-19,” said CDC Director Dr. Mandy Cohen. “CDC will continue to educate the public on how and when to get their updated vaccinations so they can risk less severe illness and do more of what they love.”